Apple cider vinegar and glucose: what's real, what's marketing
Apple cider vinegar has small but reproducible effects on post-meal glucose in some trials. A look at the size of the effect, who responds, the safety considerations, and whether it's worth the practice.
Reviewed by The Biohacking Bible editorial team
Apple cider vinegar (ACV) is one of those interventions where the wellness world's enthusiasm and the clinical evidence are both larger than zero but mismatched in scale.
What the trials show#
Several small RCTs have measured glucose response to 1–2 tablespoons of vinegar (about 15–30 ml) taken with a high-carbohydrate meal, typically diluted in water:
- Liljeberg & Björck 1998: vinegar with a white bread meal reduced post-meal glucose and insulin response.
- Mitrou et al. 2010 — type 1 diabetics; vinegar with a mixed meal modestly reduced glycemic response.
- Johnston et al. 2004 and follow-ups: vinegar improved insulin sensitivity to a high-carbohydrate meal in people with insulin resistance or type 2 diabetes.
- A 2017 meta-analysis (Shishehbor et al.) pooled the small trials and reported a statistically significant reduction in post-meal glucose, with effect sizes ranging from modest to small.
The pattern: real effect, small magnitude (typically 0.5–1.0 mmol/L peak reduction), more pronounced in people with impaired glucose tolerance.
Why it might work#
The proposed mechanism is acetic acid slowing gastric emptying and possibly inhibiting digestive enzymes that release glucose from starch. The effect is more pronounced with high-glycemic carbohydrate meals (bread, white rice) than with low-glycemic or protein-dominant meals.
The slower gastric emptying also explains why some people experience fullness or nausea after vinegar. The same mechanism that reduces glucose response can worsen GI symptoms.
What it doesn't do#
- It doesn't replace metformin or any glucose-lowering medication
- It doesn't substantially affect HbA1c over weeks (small trials show no meaningful change)
- It doesn't "detox" anything in any clinically meaningful sense
- It doesn't reduce body weight in any clinically significant way despite frequent claims
Safety considerations#
ACV's main risks:
- Tooth enamel erosion: straight vinegar is acidic (pH ~2.5); regular undiluted use damages enamel. Dilute heavily, use a straw, and rinse afterwards.
- Oesophageal irritation — undiluted vinegar can cause throat burning and oesophageal damage with frequent use.
- GI upset in some people, especially with reflux or gastroparesis.
- Potassium interactions: chronic high-dose vinegar use has been associated with hypokalaemia in rare case reports.
- Medication interactions — diuretics, digoxin, insulin (potentiation of hypoglycaemia risk).
What we'd actually say#
If you have impaired glucose tolerance or are testing ACV as a CGM experiment, 1–2 tablespoons diluted in a large glass of water with a high-carb meal is a reasonable thing to try. The effect on your post-meal curve is the most direct measure of whether you personally respond.
Expectations should be modest: a 0.5–1.0 mmol/L peak reduction is the typical trial size. That can matter for a borderline curve but doesn't transform glycemic control.
For people with type 2 diabetes, ACV is not a substitute for proper medical management. For everyone, the dental risks are real.
When to talk to a clinician#
- Type 1 or type 2 diabetes — do not add ACV to a glucose-lowering medication regimen without input
- Active reflux, oesophagitis, or gastroparesis
- On diuretics, digoxin, or laxatives (potassium concerns)
- Considering chronic high-dose ACV use (more than 30 ml/day)
When to talk to a clinician
Educational content has limits. The following are reasons to talk to a UK-registered GP, contact NHS 111, or in an emergency call 999.
- Type 1 or type 2 diabetes on glucose-lowering medication
- Active reflux, oesophagitis, or gastroparesis
- On diuretics or digoxin (potassium concerns)
- Significant dental enamel issues
Frequently asked
How much ACV is the trial dose?
Will ACV help me lose weight?
References
- Shishehbor F, Mansoori A, Shirani F (2017). Vinegar consumption can attenuate postprandial glucose and insulin responses; a systematic review and meta-analysis of clinical trials. Diabetes Res Clin Pract
- Mitrou P et al. (2010). Vinegar decreases postprandial hyperglycemia in patients with type 1 diabetes. Diabetes Care
- Johnston CS et al. (2004). Vinegar improves insulin sensitivity to a high-carbohydrate meal in subjects with insulin resistance or type 2 diabetes. Diabetes Care
Was this page useful?
Votes are pseudonymous. No account, cookie, or email needed. We aggregate feedback weekly to prioritise page reviews.
Related protocols
Last reviewed: · Evidence grade: C
Reviews check that sources are still current, that nothing has been recalled or had its MHRA status changed, and that no banned claims have crept in. See our grading methodology and corrections policy.